Upstream stimulating factor 1 (USF1) -202 G/A polymorphism and serum levels of USF1 and USF2 are associated with gastric cancer risk: a case control study
- PMID: 40102295
- PMCID: PMC11919976
- DOI: 10.1007/s00432-025-06158-1
Upstream stimulating factor 1 (USF1) -202 G/A polymorphism and serum levels of USF1 and USF2 are associated with gastric cancer risk: a case control study
Abstract
Purpose: Gastric cancer is an inflammation-driven disease often associated with a bad prognosis. Upstream stimulatory factors USF1 and USF2 are pleiotropic transcription factors, with tumor suppressor function. Low expression of USF1 is associated with low survival in gastric cancer patients. USF1 genetic polymorphism -202G > A has been associated with cancer susceptibility. Our aim was to investigate USF1 gene polymorphism and serum level with the risk of gastric cancer.
Methods: USF1-202 G/A polymorphism was analyzed by sanger sequencing, with the measure of USF1/USF2 serum levels by ELISA in H. pylori-positive patients with chronic gastritis, gastric precancerous lesions, gastric cancer and in healthy controls.
Results: Our results show that the presence of the USF1-202 A allele increased the risk of gastric cancer compared to G (OR = 2; 95% CI 1.07-3.9; P = 0.02). Genotypically and under the dominant mutation model, the combined USF1- GA/AA -202 genotypes corresponded to higher risk of gastric cancer (OR = 3.5; 95% CI 1.4-8.2; p-value = 0.005) than the GG genotype. Moreover, the G/A transition at USF1-202 was associated with lower USF1 serum level, and mostly observed in gastric cancer patients where the average serological level of USF1 were 2.3 and twofold lower for the AA and GA genotypes, respectively, compared to GG.
Conclusion: USF1-202 G/A polymorphism constitutes a gastric cancer genetic risk factor. Together with USF1/USF2 serum level, they can be proposed as promising biomarkers for gastric cancer detection/prevention.
Keywords: Biomarkers; Gastric cancer; Genetic polymorphism; Genetic risk factor; Serum.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: The study protocol has been performed in accordance with the ethical standards and was approved by the committee of Pasteur Institute of Morocco. Informed consent: Informed consent was obtained from all subjects involved in the study.
Figures




Similar articles
-
Associations of the -238(G/A) and -308(G/A) TNF-α Promoter Polymorphisms and TNF-α Serum Levels with the Susceptibility to Gastric Precancerous Lesions and Gastric Cancer Related to Helicobacter pylori Infection in a Moroccan Population.Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1623-1629. doi: 10.31557/APJCP.2020.21.6.1623. Asian Pac J Cancer Prev. 2020. PMID: 32592356 Free PMC article.
-
Association of Tumor Necrosis Factor Receptor 1 Promoter Gene Polymorphisms (-580 A/G and -609 G/T) and TNFR1 Serum Levels with the Susceptibility to Gastric Precancerous Lesions and Gastric Cancer Related to H. pylori Infection in a Moroccan Population.Biomed Res Int. 2020 Sep 24;2020:2451854. doi: 10.1155/2020/2451854. eCollection 2020. Biomed Res Int. 2020. PMID: 33029495 Free PMC article.
-
Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.Med Oncol. 2014 Dec;31(12):301. doi: 10.1007/s12032-014-0301-4. Epub 2014 Nov 1. Med Oncol. 2014. PMID: 25367853
-
Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.Tumour Biol. 2015 Apr;36(4):2551-8. doi: 10.1007/s13277-014-2871-3. Epub 2014 Dec 6. Tumour Biol. 2015. PMID: 25480412
-
[Correlation of interleukin-10-1082G/a single nucleotide polymorphism to the risk of gastric cancer in north China: a case-control study].Ai Zheng. 2008 Jan;27(1):35-40. Ai Zheng. 2008. PMID: 18184461 Chinese.
References
-
- Bounder G, Jouimyi MR, Boura H, Touati E, Michel V, Badre W et al (2020) Associations of the -238(G/A) and -308(G/A) TNF-α promoter polymorphisms and TNF-α serum levels with the susceptibility to gastric precancerous lesions and gastric cancer related to Helicobacter pylori infection in a moroccan population. Asian Pac J Cancer Prev 21(6):1623–1629 - PMC - PubMed
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424 - PubMed
-
- Bussière FI, Michel V, Mémet S, Avé P, Vivas JR, Huerre M et al (2010) H. pylori-induced promoter hypermethylation downregulates USF1 and USF2 transcription factor gene expression. Cell Microbiol 12(8):1124–1133 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials